(1) There is created in the State Treasury a special fund to be known as the Opioid Settlement Fund. The fund shall consist of the monies received by the Attorney General on behalf of the State of Mississippi from settlements of opioid litigation with distributors Cardinal Health, McKesson and AmerisourceBergen, manufacturers Purdue Pharma, Inc., Janssen Pharmaceuticals/Johnson & Johnson, Allergan and Teva, and pharmacy chains CVS, Walgreens, Walmart, and Kroger, and other defendants of related opioid litigation. The Attorney General shall deposit all of such monies into the fund after attorney fees and expenses have been paid.
(2) Abatement settlement funds shall be disbursed upon appropriation by the Legislature in accordance with the requirements of Section 41–153–1 .
(3) For abatement settlement funds, the Attorney General shall oversee the expenditure of such monies to ensure compliance with the opioid settlements.
(4) Nonabatement settlement funds shall be disbursed upon appropriation by the Legislature without any recommendations by the council regarding the use of those monies.
(5) Unexpended amounts remaining in the fund at the end of a fiscal year shall not lapse into the State General Fund, and any interest earned or investment earnings on amounts in the fund shall be deposited into such fund.